Artera

Artera

SaaS patient communications platform for healthcare

Overview

Artera provides a patient communication platform for healthcare providers that integrates with existing electronic health record (EHR) systems to streamline and unify patient messages. The product is offered as software-as-a-service (SaaS) and uses artificial intelligence to automate common patient interactions, such as appointment reminders, follow-up care instructions, and outreach, all accessible through a subscription. It differentiates itself by embedding AI-driven automation directly within EHR workflows and serving a broad base of healthcare organizations, including specialty groups, Federally Qualified Health Centers (FQHCs), and large integrated delivery networks (IDNs), with over 900 clients. The goal is to improve patient engagement and healthcare operations by delivering seamless, automated communications that fit into existing clinical processes.

About Artera

Simplify's Rating
Why Artera is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

201-500

Company Stage

Series C

Total Funding

$148.4M

Headquarters

Santa Barbara, California

Founded

2015

People at Artera

People at Artera who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Artera launched an AI Services Model for specialty care and FQHCs in May 2026 to build custom solutions.
  • Artera reached $100M in contracted annual recurring revenue and secured $65M in growth funding in 2025.
  • Atlantic Health reduced colonoscopy no-shows by 39% within 30 days using Artera's AI agents.

What critics are saying

  • Epic's AI Agent Marketplace launch in Q2 2026 displaces Artera's middleware layer with high probability.
  • Veritess's $20M Series B 'AI Co-Pilot' offers 40% lower per-seat pricing to IDNs, compressing Artera's margins.
  • FCC Voice AI Liability Rule enforcement in Jan 2027 mandates $10k+ per-hallucination fines for Artera's auto-resolved conversations.

What makes Artera unique

  • Artera is the only agentic healthcare company deploying custom AI Service Squads for bespoke front and back office solutions.
  • Artera delivers a platform-level patient communications solution integrating across EHRs, single-point solutions, apps, and more.
  • Artera’s AI agents complete 94% of conversations without staff intervention across over 1,000 healthcare organizations.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$148.4M

Above

Industry Average

Funded Over

0 Rounds

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Signify Research
Jun 24th, 2026
Voice AI in specialty patient access: Signify Research partners with Artera on independent research.

Voice AI in specialty patient access: Signify Research partners with Artera on independent research. Share: Vlad Kozynchenko Published: June 24, 2026 In The News Cranfield, UK, 24th June 2026, Featured in Yahoo Finance (via PR Newswire) - Signify Research has partnered with Artera, a healthcare communications and agentic technology company, to publish independent research examining how specialty healthcare leaders should evaluate, select, and deploy Voice AI for patient access. The report was distributed via PR Newswire and featured on Yahoo Finance on 24 June 2026. The research, led by Vlad Kozynchenko, Senior Market Analyst at Signify Research, draws on primary interviews with specialty group leaders across dermatology, ophthalmology, orthopaedics, and multispecialty organisations across North America. Its central finding is that the majority of Voice AI pilots are failing not because of technological shortcomings, but because evaluation criteria are mismatched to the operational realities of specialty care environments. The report introduces a five-step evaluation framework and vendor assessment checklist, covering scheduling integrity, EHR integration depth, clinical escalation logic, and return on investment measurement. Signify Research's involvement as an independent third party was commissioned to provide specialty leaders with an objective resource for vendor assessment, regardless of which solution they ultimately select. About vladimir Kozynchenko - Senior Market Analyst, Digital Health. Vladimir Kozynchenko joined Signify Research in 2023. He brings a strong background in strategy consulting and market intelligence, with experience leading commercial strategy, market planning, and due diligence projects for governments, operators, healthcare providers, and technology vendors. At Signify Research, Vlad works closely with clients on custom research and advisory engagements across the digital health landscape, helping organisations navigate evolving market dynamics, competitive positioning, and growth opportunities. About Signify Research. Signify Research is a specialist healthtech market intelligence firm, providing data-driven insights that help vendors, investors, and health system leaders make better strategic decisions. Headquartered in the UK and serving clients across North America, Europe, and Asia-Pacific, Signify Research combines primary research, including in-depth interviews with technology vendors and healthcare professionals, with sales data reported directly by leading vendors, to deliver the most complete and authoritative view of global healthtech markets. Coverage spans five core areas: Medical Imaging, Clinical Care, Digital Health, Diagnostics and Lifesciences, and Healthcare IT, with dedicated analyst expertise across AI in Healthcare. Clients benefit from direct access to specialist analysts, off-the-shelf market reports and subscriptions, and custom research services tailored to specific strategic needs. Signify Research's methodology is independent and impartial, underpinned by a commitment to quality, transparency, and actionable intelligence. You may also like

PR Newswire
Mar 30th, 2026
Atlantic Health cuts colonoscopy no-shows by 39% with Artera's AI agents

Atlantic Health, a New Jersey-based healthcare system, has deployed Artera's AI Agents to improve colonoscopy screening rates and reduce appointment cancellations. The system uses automated calls to guide patients through the complex preparation process for colorectal cancer screening. Within the first 30 days, 43% of contacted patients confirmed their identities, 39% confirmed attendance at upcoming appointments, and 7% asked procedure-related questions. The AI Agent handles over 80 approved clinical and operational queries in multiple languages, reducing manual call time by 38%. Atlantic Health selected Artera's technology to standardise patient outreach across its organisation, addressing high cancellation rates caused by confusing multi-day preparation requirements. Colorectal cancer remains the leading cause of death for adults under 50 in the US, with nearly one-third of eligible adults remaining unscreened.

PR Newswire
Mar 26th, 2026
Artera appoints new CTO and promotes people leader after $65M funding round

Artera, a healthcare communications platform combining human and AI agent intelligence, has appointed Damon Lanphear as chief technology officer and promoted Nicole Ossey to senior vice president of people. The moves follow Artera's recent $65 million growth investment. Lanphear brings over 30 years of experience, most recently leading technology for three Amazon business units including AWS and Kindle devices. He previously co-founded and served as CTO at 98point6, an AI-powered primary healthcare pioneer. Ossey, with 13 years in B2B SaaS, has been with Artera for two years. She previously helped scale Knock from 30 to 200 employees before its acquisition by RealPage. Artera supports two billion patient communications annually and has deployed AI agents across hundreds of healthcare providers, completing 94% of conversations without staff intervention.

MobiHealthNews
Mar 26th, 2026
Q&A: Artera's new CTO on bringing Amazon expertise to AI health tech strategy.

Q&A: Artera's new CTO on bringing Amazon expertise to AI health tech strategy. Damon Lanphear, Artera's new CTO and former Amazon leader, shares his vision for advancing the company's technology. Damon Lanphear, chief technology officer at Artera California-based Artera, an agentic AI company that aims to help healthcare providers with patient communication, announced today the appointment of Damon Lanphear as its new chief technology officer. Lanphear formerly held leadership positions across three business units at Amazon - Amazon Web Services (AWS) Snow, AWS Managed Services and Amazon Devices - and oversaw technical strategy for Kindle and Scribe devices. The new CTO sat down with MobiHealthNews to discuss how he plans to apply his Amazon experience to advance Artera's technology strategy. MobiHealthNews: What are your plans as Artera's new chief technology officer? Damon Lanphear: I think the exciting thing that drew me to Artera right from the get-go was how well-positioned Artera is to help create a really delightful experience around patient communication and a really delightful experience around clinic operations. Mobihealthnews is at this amazing inflection point right now where, with the advances in LLMs [large language models] and foundation models, Mobihealthnews now have the ability to go way deeper and way broader with respect to the nuance and the dimensionality that Mobihealthnews can support for patient communications. Mobihealthnews all know that today patients are well-served with systems that allow them to sort of navigate through a set of options. Mobihealthnews is all familiar with these. And now Mobihealthnews is able to enter this phase where Mobihealthnews can have patients tell more about their conditions, tell more about the specific scenarios, and in doing so, feel heard, have their needs met more directly. Clinic operators can actually focus on the patients who need the most attention. And so bringing that vision to life is my mission right now. I think one of the key things for me and the big learnings has been through my career working with AI, and I've been working with AI probably since, you know, long before Mobihealthnews were using the term "AI" more broadly in the mainstream media, dating back to maybe 2005/2006, it is understanding that getting very, very close to the customer, being able to understand their needs and being able to craft the system to meet those needs is absolutely critical to bring this vision to life. And I think what I love about Artera is how close Artera is to its customers. They support them from the first step in doing the implementation, all the way through the long-term engagement and using that as a vehicle to help drive these types of improvements and help realize this vision. MHN: There is a lot with AI that you have to be cautious of. What are you bringing to Artera that you learned from Amazon, including some cautions around AI and making sure that things are done without hallucinations? Lanphear: Referring back to the AWS and Amazon experience, one of the great things about having had that experience in my career is, you know, Amazon is very famously very disciplined around security and privacy for both AWS and its retail and its devices and operations. That understanding of how you systematically manage security and privacy at scale, and to be very thorough and deep in the translation of that, too. And there are a lot of different ways that security and privacy read on both you prompting the flow of information through your systems, as well as considerations around patient safety, and not the least of which is related to like your prompt engineering, but it's also all the systems that support in or around that. And so much of what Mobihealthnews do here and Mobihealthnews has been successful at doing through its pursuit of FedRAMP High, which is in progress, and the work that Mobihealthnews has done historically to its HIPAA posture, all of that sets the right framework for Mobihealthnews to be able to say, how do Mobihealthnews provide the same type of guardrails for the processing of information to maintain patient privacy, to make sure that Mobihealthnews is keeping the conversations within the context of systems that Mobihealthnews has direct observability and control over, ensuring that Mobihealthnews can apply guardrails for patient safety that are well vetted with its clinical experts is all part of the design of its system and how Mobihealthnews is carrying this forward. One of the great things that Mobihealthnews is doing with the development of AI scheduling, which Mobihealthnews is deploying with customers right now, is working closely with them on their standard operating procedures and translating those standard operating procedures in a way that its LLM-based, agentic-capable solutions are actually following, and Mobihealthnews can do that in a way that's verifiable. So Mobihealthnews can actually give proof so that its operational partners on the clinic side can trust what Mobihealthnews is doing, that Mobihealthnews is following their clinical best practices, their standards of care, and have that be at the baseline from which Mobihealthnews is building. MHN: Do you have any ideas for what could be adjusted within Artera as far as technology goes? Lanphear: Yeah, I mean I think there's definitely big, you know, I just touched on this concept of how standard operating procedures [SOPs] are brought to bear to help guide what LLM-based solutions are doing, and what is exciting in that space is that you have an opportunity to actually bring reasoning models to evaluate how those SOPs are represented. So, for example, a standard operating procedure might be represented in a clinic as a binder, sticky notes or notes on a whiteboard. It might be in the minds of the people who are guiding the clinical operations staff. Being able to bring all of that context together in one place and accurately represent it, but also be able to inspect it and raise questions about, hey, how can Mobihealthnews make this better? And there's really a special opportunity to do that here. And the reason why that's so critical is because it helps to facilitate the ease of the onboarding and integration. So if you think about bringing a solution like Artera to bear on your clinic, there's going to be this integration phase. New technology. How do Mobihealthnews configure it? How do I get it working? And if Mobihealthnews make that easier and simpler to understand while maintaining trust, that's a huge win.

PR Newswire
Feb 27th, 2026
Artera named #1 Best in KLAS for patient communications with 89.8 performance score

Artera, a patient communications platform combining human and AI agent intelligence, has been named #1 Best in KLAS for Patient Communications. The Santa Barbara-based company received an overall performance score of 89.8, earning straight A- grades across all six evaluation categories: Culture, Loyalty, Operations, Product, Relationship and Value. The recognition follows significant growth for Artera, which recently surpassed $100 million in Contracted Annual Recurring Revenue. Founded over a decade ago, the company now serves more than 1,000 healthcare provider organisations and manages two billion patient communications annually. The award adds to Artera's existing accolades, including five consecutive years on the Inc. 5000 list and six years on Deloitte's Technology Fast 500. Over 100 healthcare providers have deployed Artera's AI agents, which complete 94% of conversations without staff intervention.

Recently Posted Jobs

Sign up to get curated job recommendations

Artera is Hiring for 9 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →